Langerhans cell histiocytosis with <i>BRAF</i> p.N486_P490del or <i>MAP2K1</i> p.K57_G61del treated by the MEK inhibitor trametinibYoav H. Messinger, Michael K. Richards, Bruce Bostrom et al.|Pediatric Blood & Cancer|2020Cited by 20
Symptomatic Hyperammonemia With Erwinia chrysanthemi–derived Asparaginase in Pediatric Leukemia PatientsNathan Gossai, Bruce Bostrom, L.H. Boman et al.|Journal of Pediatric Hematology/Oncology|2018Cited by 15
Pediatric Acquired von Willebrand Disease With Berlin Heart Excor Ventricular Assist Device SupportNathan Gossai, Marie E. Steiner, Nicholas M Brown et al.|World Journal for Pediatric and Congenital Heart Surgery|2016Cited by 9
Outcome of Infants Treated on Total Therapy for Infants with Acute Lymphoblastic Leukemia I: Results from a Non-Randomized Multi-Center StudyTanja A. Grüber, Paul S. Gaynon, Minxuan Huang et al.|Blood|2023Cited by 7
Langerhans Cell Histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del Treated by the MEK Inhibitor TrametinibYoav H. Messinger, Michael Richards, Bruce Bostrom et al.|Unknown|2020Cited by 2